Literature DB >> 25462564

Syndecan-1 responsive microRNA-126 and 149 regulate cell proliferation in prostate cancer.

Tomomi Fujii1, Keiji Shimada1, Yoshihiro Tatsumi2, Kiyohide Fujimoto3, Noboru Konishi4.   

Abstract

MicroRNAs (miRNAs) are short (19-24 nt), low molecular weight RNAs that play important roles in the regulation of target genes associated with cell proliferation, differentiation, and development, by binding to the 3'-untranslated region of the target mRNAs. In this study, we examined the expression of miRNA-126 (miR-126) and miR-149 in prostate cancer, and investigated the molecular mechanisms by which they affect syndecan-1 in prostate cancer. Functional analysis of miR-126 and miR-149 was conducted in the prostate cancer cell lines, PC3, Du145, and LNCaP. The expression levels of SOX2, NANOG, Oct4, miR-126 and miR-149 were evaluated by quantitative RT-PCR. After silencing syndecan-1, miR-126, and/or miR-149 in the PC3 cells, cell proliferation, senescence, and p21 induction were assessed using the MTS assay, senescence-associated β-galactosidase (SA-β-Gal) assay, and immunocytochemistry, respectively. Compared to the Du145 and LNCaP cells, PC3 cells exhibited higher expression of syndecan-1. When syndecan-1 was silenced, the PC3 cells showed reduced expression of miR-126 and miR-149 most effectively. Suppression of miR-126 and/or miR-149 significantly inhibited cell growth via p21 induction and subsequently, induced senescence. The mRNA expression levels of SOX2, NANOG, and Oct4 were significantly increased in response to the silencing of miR-126 and/or miR-149. Our results suggest that miR-126 and miR-149 are associated with the expression of syndecan-1 in prostate cancer cells. These miRNAs promote cell proliferation by suppressing SOX2, NANOG, and Oct4. The regulation of these factors by miR-126 and miR-149 is essential for syndecan-1-mediated development of androgen-refractory prostate cancer.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MiR-126; MiR-149; MicroRNA; Prostate cancer; Syndecan-1

Mesh:

Substances:

Year:  2014        PMID: 25462564     DOI: 10.1016/j.bbrc.2014.11.056

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

Review 1.  Regulation of NANOG in cancer cells.

Authors:  Shuai Gong; Qiuhui Li; Collene R Jeter; Qingxia Fan; Dean G Tang; Bigang Liu
Journal:  Mol Carcinog       Date:  2015-05-27       Impact factor: 4.784

Review 2.  Regulation and functions of MicroRNA-149 in human cancers.

Authors:  Yingru Zhi; Hao Zhou; Abudoureyimu Mubalake; Ying Chen; Bei Zhang; Kai Zhang; Xiaoyuan Chu; Rui Wang
Journal:  Cell Prolif       Date:  2018-07-12       Impact factor: 6.831

3.  Enhanced SOX2 expression in retinoblastoma tissues and peripheral blood is associated with the clinicopathological characteristics of the disease.

Authors:  Boding Tong; Jiexi Zeng; Yujie Wu; Wei Xiong
Journal:  Oncol Lett       Date:  2015-01-07       Impact factor: 2.967

4.  microRNA-145 promotes differentiation in human urothelial carcinoma through down-regulation of syndecan-1.

Authors:  Tomomi Fujii; Keiji Shimada; Yoshihiro Tatsumi; Kinta Hatakeyama; Chiho Obayashi; Kiyohide Fujimoto; Noboru Konishi
Journal:  BMC Cancer       Date:  2015-10-29       Impact factor: 4.430

Review 5.  Epigenetic and miRNAs Dysregulation in Prostate Cancer: The role of Nutraceuticals.

Authors:  Alessandra Bosutti; Fabrizio Zanconati; Gabriele Grassi; Barbara Dapas; Sabina Passamonti; Bruna Scaggiante
Journal:  Anticancer Agents Med Chem       Date:  2016       Impact factor: 2.505

Review 6.  The role of glycans in the development and progression of prostate cancer.

Authors:  Jennifer Munkley; Ian G Mills; David J Elliott
Journal:  Nat Rev Urol       Date:  2016-04-19       Impact factor: 14.432

7.  Molecular Subtyping of Serous Ovarian Cancer Based on Multi-omics Data.

Authors:  Zhe Zhang; Ke Huang; Chenglei Gu; Luyang Zhao; Nan Wang; Xiaolei Wang; Dongsheng Zhao; Chenggang Zhang; Yiming Lu; Yuanguang Meng
Journal:  Sci Rep       Date:  2016-05-17       Impact factor: 4.379

8.  MicroRNA-331-3p Suppresses Cervical Cancer Cell Proliferation and E6/E7 Expression by Targeting NRP2.

Authors:  Tomomi Fujii; Keiji Shimada; Aya Asano; Yoshihiro Tatsumi; Naoko Yamaguchi; Masaharu Yamazaki; Noboru Konishi
Journal:  Int J Mol Sci       Date:  2016-08-18       Impact factor: 5.923

Review 9.  miR-149 in Human Cancer: A Systemic Review.

Authors:  Yunjie He; Dandan Yu; Lingping Zhu; Shanliang Zhong; Jianhua Zhao; Jinhai Tang
Journal:  J Cancer       Date:  2018-01-01       Impact factor: 4.207

10.  Mining of potential microRNAs with clinical correlation - regulation of syndecan-1 expression by miR-122-5p altered mobility of breast cancer cells and possible correlation with liver injury.

Authors:  YihHuei Uen; Jin-Wun Wang; ChiaChen Wang; Yaoyun Jhang; Jo-Yun Chung; TingTing Tseng; MingJen Sheu; ShaoChen Lee
Journal:  Oncotarget       Date:  2018-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.